Patents by Inventor Daniel Gaudet

Daniel Gaudet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190197375
    Abstract: The invention relates to traceable metallic products, methods of uses and methods of making same. The metallic products may be made traceable for integrity purposes, identification purposes, counterfeit avoidance and the like. The invention also relates to metallic supports for nanostorage of various compounds and samples.
    Type: Application
    Filed: January 11, 2019
    Publication date: June 27, 2019
    Inventors: Steve Arsenault, Daniel Gaudet, Daniel Rivard, Maxime Dumont, Jocelyn Lambert
  • Publication number: 20160267368
    Abstract: The invention relates to traceable metallic products, methods of uses and methods of making same. The metallic products may be made traceable for integrity purposes, identification purposes, counterfeit avoidance and the like. The invention also relates to metallic supports for nanostorage of various compounds and samples.
    Type: Application
    Filed: October 17, 2014
    Publication date: September 15, 2016
    Applicant: 9163-0384 Quebec Inc.
    Inventors: Steve ARSENAULT, Daniel GAUDET, Daniel RIVARD, Maxime DUMONT, Jocelyn LAMBERT
  • Publication number: 20100087462
    Abstract: The invention describes methods and tools for the identification of drug intolerance into subjects receiving an hypolipidemic agent. The invention further describes methods and tools for the prediction of drug intolerance in subjects in need of hypolipidemic agents. Some aspects of the invention are based on the assessment of the subject plasma glycerol concentrations. Some aspects of the invention are based on the assessment of the subject HDL-triglycerides concentration. Some other aspects are based on the identification of hepatic lipase gene variants in a subject genome.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 8, 2010
    Applicant: BOREAL PHARMA RECHERCHE CLINIQUE
    Inventors: Daniel GAUDET, Marta SANTURE, Diane BRISSON, Gerald TREMBLAY
  • Publication number: 20080319176
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Application
    Filed: February 25, 2008
    Publication date: December 25, 2008
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark Daly
  • Publication number: 20040259134
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Application
    Filed: April 19, 2004
    Publication date: December 23, 2004
    Applicants: Whitehead Institute for Biomedical Research, Complexe Hospitalier de la Sagamie
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark J. Daly
  • Patent number: 6833240
    Abstract: Polymorphic nucleic acid molecules encoding the very low density lipoprotein receptor are described, as well as gene products encoded by these nucleic acid molecules. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also described, along with methods of use therefor.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: December 21, 2004
    Assignees: McGill University, Complexe Hospitalier de la Sagamie
    Inventors: James C. Engert, Marie-Claude Vohl, Carl Brewer, Kenneth Morgan, Daniel Gaudet, Thomas J. Hudson
  • Patent number: 6743579
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: June 1, 2004
    Assignees: Whitehead Institute for Biomedical Research, Complexe Hospitalier de la Sagamie
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark Daly
  • Publication number: 20030165977
    Abstract: The complete genomic structure of the peroxisome proliferator-activated receptor alpha gene is described. Also described are the identification of novel single nucleotide polymorphisms and association with higher plasma LDL-cholesterol and total and LDL-apolipoprotein B concentrations.
    Type: Application
    Filed: April 7, 2003
    Publication date: September 4, 2003
    Applicant: Complexe Hospitalier de la Sigamie
    Inventors: Thomas J. Hudson, Marie-Claude Vohl, Carl Brewer, Kenneth Morgan, Daniel Gaudet
  • Patent number: 6544743
    Abstract: The complete genomic structure of the peroxisome proliferator-activated receptor alpha gene is described. Also described are the identification of novel single nucleotide polymorphisms and association with higher plasma LDL-cholesterol and total and LDL-apolipoprotein B concentrations.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: April 8, 2003
    Assignees: McGill University, Complexe Hospitalier de la Sagamie
    Inventors: Thomas J. Hudson, Marie-Claude Vohl, Carl Brewer, Kenneth Morgan, Daniel Gaudet
  • Publication number: 20030032099
    Abstract: Methods for determining an individual's susceptibility to obesity or to a health disorder associated with obesity, comprising detecting an allele at a polymorphic site genetically linked to the resistin gene locus, wherein the allele is further linked to obesity, and wherein detection of the allele is indicative of the patient's susceptibility to a health disorder associated with obesity are provided. Also included in the present disclosure are nucleic acid molecules containing allelic variants at polymorphic sites.
    Type: Application
    Filed: April 4, 2002
    Publication date: February 13, 2003
    Inventors: Thomas J. Hudson, James C. Engert, Daniel Gaudet, Pierre Lepage, Marie-Claude Vohl, Scott M. Williams
  • Publication number: 20020155446
    Abstract: Polymorphic nucleic acid molecules encoding the very low density lipoprotein receptor are described, as well as gene products encoded by these nucleic acid molecules. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also described, along with methods of use therefor.
    Type: Application
    Filed: March 8, 2001
    Publication date: October 24, 2002
    Applicant: McGill University
    Inventors: James Engert, Marie-Claude Vohl, Carl Brewer, Kenneth Morgan, Daniel Gaudet, Thomas J. Hudson
  • Patent number: 6280778
    Abstract: A process is disclosed, for preparing a derivative of a targeted natural product from plants. The targeted natural product is extracted from the desired part of the plant and the targeted natural product is transformed into the desired derivative(s). Both the extraction and transformation are carried out in a single step consisting of macerating the desired part of the plant into a composition comprising an organic solvent and a reactive agent. This process is particularly useful for preparing derivatives of betulin or lupeol from bark of birch.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: August 28, 2001
    Inventors: Daniel Gaudet, André Pichette